Pre-Open Movers 09/23: (MNOV) (ATHX) (NKE) Higher; (ACIU) (WVE) (SFIX) Lower (more...)

Go back to Pre-Open Movers 09/23: (MNOV) (ATHX) (NKE) Higher; (ACIU) (WVE) (SFIX) Lower (more...)

Medicinova (MNOV) Reports Publication of Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy

September 24, 2020 6:31 AM EDT

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced positive clinical findings published in Cancer Chemotherapy and Pharmacology regarding MN-166 (ibudilast) as a treatment for prevention of chemotherapy-induced peripheral neuropathy (CIPN).

The publication, entitled Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability, and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer, is the result of a collaborative effort between MediciNova and Dr.... More